Nov 04, 2015

Could Your Blood Type Influence Susceptibility to Alzheimer’s?

A new research study from the University of Sheffield suggests that our blood type may have more of an influence on protecting our brain from disease than previously thought.
A promising development that may have the potential to unveil another piece of the puzzle supporting Alzheimer’s research.

The University of Sheffield journal Brain Research Bulletin, suggests that individuals with ‘Type O’ blood have larger grey matter in the cerebellum. The region of the brain involved with seeing and hearing, memory, emotions, speech and decision making.

Grey matter a major component of the central nervous system, comprising of numerous brain cells including neurons. Often found to be on of the first areas damaged in people with Alzheimer’s disease. People with larger grey matter may have more reserve before negative effects take place. While further research needs to be done, this suggests that our blood type may yet provide some clues to susceptibility.

The aim of the study was to compare the grey matter volumes of 189 cognitively healthy adults. Of the participants, 76 adults had Type O blood, 65 adults had Type A blood while the others had either Type AB or B blood. All participants were scanned using an MRI brain scanning technique to measure the volume of the grey matter. The researchers found that participants with Type O blood had more grey matter in the posterior proportion of the cerebellum. Those with ‘A’, ‘B’ or ‘AB’ blood types had more grey matter volumes in both temporal (responsible for memory and language) and limbic regions (responsible for emotions, memories and arousal) of the brain, including the left hippocampus. With the hippocampus one of the areas of the brain affected by Alzheimer’s disease.

Dr Matteo De Marco, research fellow at the University of Sheffield’s Department of Neuroscience, stated that the findings indicated that individuals with ‘O’ blood type have more protection against particular diseases where the volumetric reduction is seen in temporal regions of the brain, with Alzheimer’s disease being a classic example.

Dr DeMarco was clear to emphasise, however, that the community must not to jump to conclusion and assume that blood type can decrease or increase our risk of dementia. Further, individuals with A, B or AB blood types should not assume that they are at higher risk of dementia or Alzheimer’s until further research is performed. Although still in early stages requiring additional tests and further research. It’s another step forward in the search for a greater understanding for the causes of the disease.

Vicki Tuchtan, Academic Director at Sage Institute of Education

Vicki Tuchtan is the Academic Director at Sage Institute of Education. She oversees learning processes, teaching outcomes, resources and course development. A passionate advocate for bettering standards of Aged Care Training.

Leave a Reply

Your email address will not be published. Required fields are marked *

Advertisement
Advertisement
Advertisement

Euthanasia – The People Who Are Choosing Death Before Dementia

When it comes to categorising and understanding dementia, there is an air of uncertainty that can inhibit the uniform approach to treatment that can be taken with other ailments or forms of disease. Dementia itself is not actually a disease, but rather a collection of varying symptoms that are caused by disorders of the brain,... Read More

Dementia Increases Hospital Readmission Risk

Living with a diagnosis of dementia can make many older people at increased risk to other health conditions, infections and falls. Research shows that due to this increase people with dementia also have multiple hospital admissions, more so than those without the condition. A recent research has looked into the rates of readmission of older people, and... Read More

Paper highlights mental health impacts of COVID-19 on people living with dementia, families, carers

The need to address the loneliness and isolation experienced by people impacted by dementia has been brought in to sharp focus by the COVID-19 pandemic, according to a discussion paper released by Dementia Australia today. Federal parliamentarians, government officials, key stakeholders and dementia advocates will today convene online with the Parliamentary Friends of Dementia to... Read More
Advertisement